Go Deep
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,440 | -0.6 | 0.37 | 0.20 | 83.92 |
| Oct 2026 | 21,194 | -0.7 | 0.41 | 0.20 | 92.34 |
| Oct 2026 | 21,396 | -0.6 | 0.38 | 0.20 | 85.23 |
| Oct 2026 | 21,399 | -0.6 | 0.38 | 0.20 | 85.21 |
| Oct 2026 | 21,361 | -0.6 | 0.39 | 0.20 | 86.51 |
| Oct 2026 | 21,435 | -0.6 | 0.37 | 0.20 | 83.78 |
| Oct 2026 | 21,492 | -0.6 | 0.36 | 0.20 | 81.68 |
| Oct 2026 | 21,496 | -0.6 | 0.36 | 0.20 | 81.85 |
Pliant Therapeutics, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -22,371,000.0 | -20,040,000.0 | -23,577,000.0 | -26,301,000.0 |
| EPS | -0.4 | -0.3 | -0.4 | -0.4 |
Pliant Therapeutics, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 1,580,000.0 | 9,685,000.0 | — |
| Net Profit | -149,344,000.0 | -210,304,000.0 | -161,336,000.0 | -123,321,000.0 | — |
| EPS | -2.4 | -3.5 | -2.8 | -2.9 | — |
Pliant Therapeutics, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 225,228,000.0 | 396,949,000.0 | 512,154,000.0 | 350,613,000.0 | — |
| Total Liabilities | 44,023,000.0 | 92,868,000.0 | 38,578,000.0 | 37,271,000.0 | — |
| Total Equity | 181,205,000.0 | 304,081,000.0 | 473,576,000.0 | 313,342,000.0 | — |
Owes vs Owns
Pliant Therapeutics, Inc. owed $0.23 for every $1 it owned in Jun 2026, up from $0.11 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.23× | 0.20× | 0.23× | 0.08× | 0.11× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Pliant Therapeutics, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 84.8%Fixed assets (tangible) 11.9%Other assets 2.9%
How it's funded — Dec 2025
Short-term debt 0.6%Long-term debt 12.3%Other liabilities 6.4%Shareholders' equity 80.5%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 190.9 | 355.7 | 494.2 | 331.2 |
| Receivables | 0.8 | 2.3 | 3.0 | 3.1 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 26.9 | 32.8 | 4.8 | 9.9 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 6.6 | 6.2 | 10.1 | 6.4 |
| Liabilities & equity | ||||
| Short-term debt | 1.4 | 0.5 | 1.3 | 2.5 |
| Long-term debt | 27.7 | 30.2 | 10.1 | 9.9 |
| Payables | 0.5 | 6.0 | 4.5 | 1.6 |
| Other liabilities | 14.4 | 56.2 | 22.7 | 23.3 |
| Shareholders' equity | 181.2 | 304.1 | 473.6 | 313.3 |
| Net tangible assets | 181.2 | 304.1 | 473.6 | 313.3 |
Pliant Therapeutics, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -128,336,000.0 | -155,503,000.0 | -116,361,000.0 | -94,631,000.0 | — |
| Investing Activities | 134,290,000.0 | 140,340,000.0 | -127,012,000.0 | -150,204,000.0 | — |
| Financing Activities | -31,697,000.0 | 23,117,000.0 | 274,405,000.0 | 226,854,000.0 | — |